Dr. Eric Lagasse is the Chief Scientific Officer of LyGenesis, Inc., a company that raised $3 million in Series A funding from Juvenescence, Ltd. to continue researching their innovative work in “organ regeneration using a patient’s own lymph nodes.”
For the official press release, please click here.
The Pittsburgh Post-Gazette article on the announcement can be reached by clicking here.
More information on the company is available at their website: www.lygenesis.com.
